Table 3b.
Rate Reduction | Acute ACS | Chronic ACS | Elective |
---|---|---|---|
High MA penetration counties | |||
1% | 0.06** (0.002, 0.11) | 0.12*** (0.04, 0.19) | 0.03 (−0.06, 0.11) |
5% | 0.29** (0.01, 0.57) | 0.61*** (0.22, 0.99) | 0.14 (−0.30, 0.58) |
10% | 0.59** (0.02, 1.17) | 1.2*** (0.46, 2.03) | 0.28 (−0.62, 1.19) |
Low MA penetration counties | |||
1% | 0.03 (−0.03, 0.09) | 0.07* (−0.01, 0.15) | 0.04 (−0.04, 0.13) |
5% | 0.16 (−0.15, 0.46) | 0.35* (−0.06, 0.76) | 0.22 (−0.21, 0.66) |
10% | 0.32 (−0.30, 0.9) | 0.71* (−0.13, 1.55) | 0.45 (−0.44, 1.35) |
Notes. Robust standard errors (95% confidence intervals) in parentheses.
Statistically significant at 10%.
5%.
1%. 398 county-year observations from 74 counties in Arizona, Florida, and New York, 1999–2005 with at least 10,000 Medicare beneficiaries and 3% MA penetration. Medicare Advantage payments expressed as the natural logarithm of the monthly per-enrollee MA county payment rate (U.S.$2005). Low penetration variable indicates counties with MA enrollment below 16%. Models control for county and year fixed effects.
ACS, ambulatory care sensitive.